Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-27T19:44:22.709Z Has data issue: false hasContentIssue false
  • English
  • Français

Motor neurone disease

Published online by Cambridge University Press:  17 November 2008

Hardev S Pall
Hardev S Pall*
Affiliation:
University of Birmingham. Birmingham, UK
*
Hardev S Pall University Department of Clinical Neuroscience and Regional Centre for Neurology, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 5 , Issue 3 , August 1995 , pp. 303 - 311
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Hudson, AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217–47.Google Scholar
2Salazar, AM, Masters, CL, Gajdusek, DC, Gibbs, CJ. Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt–Jakob disease. Ann Neurol 1983; 14: 17–26.CrossRefGoogle ScholarPubMed
3Hayashi, H, Kato, S, Kawada, T, Tsubaki, T. Amyotrophic lateral sclerosis: oculomotor function in patients on respirators. Neurology 1987; 37: 1431–32.CrossRefGoogle ScholarPubMed
4Swash, M, Leigh, N. Criteria for diagnosis of familial amyotrophic lateral sclerosis (workshop report of the European FALS Collaborative Group). Neuromuscul Disord 1992; 2: 7–9.CrossRefGoogle Scholar
5La Spada, AR, Wilson, EM, Lubahn, DB et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77–79.CrossRefGoogle ScholarPubMed
6Thomas, PK, Young, E, King, RHM. Sandhoff disease mimicking adult onset bulbospinal neuronopathy. J Neurol Neurosurg Psychiatry 1989; 52: 1103–106.Google Scholar
7Sumner, AJ. Separating motor neurone diseases from pure motor neuropathies: multifocal motor neuropathy with persistent conduction block. Adv Neural 1991 56: 399–403.Google Scholar
8Pall, HS. Metals and free radicals. In: Williams, AC ed. Motor neurone disease. London: Chapman nd Hall, 1994: 497–534.Google Scholar
9Olivares, L, Esteban, ES, Alter, M. Mexican resistance to amyotrophic lateral sclerosis. Arch Neural 1972; 27: 397–402.CrossRefGoogle ScholarPubMed
10Gunnarsson, LG, Palm, R. Motor neurone disease and heavy manual labour: an epidemiologie survey of Varmland County, Sweden. Neuroepidemiology 1984; 3: 195–206.CrossRefGoogle Scholar
11Patten, BM, Zito, G, Harati, Y. Histological findings in motor neurone disease. Relation to clinically determined activity, duration and severity of disease. Arch Neural 1979; 36: 560–564.Google Scholar
12Leigh, PN, Whitwell, H, Garofalo, Q et al. Ubiquitin immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution and specificity. Brain 1991; 114: 775–88.Google Scholar
13Heafield, MTE, Fearn, S, Steventon, GB et al. Plasma cysteine and sulphate levels in motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett 1990; 110: 216–20.Google Scholar
14Perl, TM, Bedard, L, Kosatsky, T et al. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. New Engl J Med 1990; 322: 1775–80.Google Scholar
15Jubelt, B. Viruses and motor neurone diseases. Adv Neurol 1991; 56: 463–72.Google Scholar
16Appel, SH, Stockton-Appel, V, Stewart, SS et al. Amyotrophic lateral sclerosis: associated clinical disorders and immunologic evaluations. Arch Neural 1986; 43: 234–38.Google Scholar
17Appel, SH, Engelhardt, JI, Garcia, J et al. Immunoglobulins from animal models of motor neurone disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci USA 1991; 88: 647–51.Google Scholar
18Rosen, DR, Siddique, T, Patterson, D et al. Mutations in Cu Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.Google Scholar
19Pall, HS, Williams, AC, Chirico, S et al. Concentrations of reduced and oxidised forms of ascorbic acid in serum and cerebrospinal fluid from patients with motor neurone disease. Neurology 1990; 40 (suppl 1): 317.Google Scholar
20Rothstein, JD, Kuncl, RW, Chaudhry, V et al. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neural 1991; 30: 224–25.CrossRefGoogle ScholarPubMed
21Sobue, G, Sahashi, K, Takahashi, A et al. Degenerating compartment and functioning compartment of motor neurones in ALS: possible process of motor neurone loss. Neurology 1983; 33: 654–57.Google Scholar
22Brooks, BR, Lewis, D, Rawling, J et al. The natural history of amyotrophic lateral sclerosis. In: Williams, AC ed. Motor neurone disease London: Chapman and Hall, 1994: 131–69.Google Scholar
23Bensimon, G, Lacomblez, L, Meininger, V et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585–91.Google Scholar
24Brewin, TB. Three ways of giving bad news. Lancet 1991; 337: 1207–209.CrossRefGoogle ScholarPubMed
25Jowett, S, Armitage, S. Hospital and community liaison links in nursing: the role of the liaison nurse. J Adv Nurs 1988; 13: 579–87.Google Scholar